Gain Therapeutics

Quarterly Financials

Values in thousands 2024-06-30 2024-03-31 2023-12-31 2023-09-30
Revenue
$0
$0
$64
$0
Gross Profit
-20
-20
41
-20
EBITDA
-8,162
-4,357
-4,383
-4,967
EBIT
-8,182
-4,377
-4,407
-4,987
Net Income
-8,143
-4,014
-4,723
-4,718
Net Change In Cash
0
0
64
0
Free Cash Flow
-5,777
-3,586
-5,660
-3,967
Cash
16,936
10,641
11,794
4,272
Basic Shares
19,215
17,978
16,206
12,701

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$55
$140
$164
$28
Gross Profit
-25
75
-6,999
-2,230
EBITDA
-22,172
-17,680
-13,753
-3,373
EBIT
-22,253
-17,745
-13,768
-3,382
Net Income
-22,267
-17,590
-13,890
-3,577
Net Change In Cash
55
140
164
28
Cost of Revenue
-29,545
Free Cash Flow
-18,881
-14,811
-12,459
-3,261
Cash
11,794
7,311
36,880
7,492
Basic Shares
13,011
11,883
10,165
11,876

Earnings Calls

Quarter EPS
2024-06-30
-$0.42
2024-03-31
-$0.22
2023-12-31
-$0.36
2023-09-30
-$0.37